Answers to previous posts and other source of information have indicated that "Patients with EGFR do not respond as well to immunotherapy as others. Patients with EGFR should exhaust all other options before trying immunotherapy, including chemotherapy which can be very effective." Does this hold true for patients with high levels (70%) of PDL1 expression?
Sun, 04/08/2018 - 13:49#1
Immunotherapy treatment of EGFR/T790M after progression - 1294190